Return to Article Details OPTIMIZING AMINOGLYCOSIDE DOSING IN CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE PATIENTS UNDERGOING INTERMITTENT HEMODIALYSIS: CARDIOVASCULAR IMPLICATIONS AND CLINICAL OUTCOMES Download Download PDF